Shein’s plans to go public in the UK are likely to be delayed until the second half of the year due to the U.S. government’s move to eliminate the de minimis import rule, the Financial Times reported. The fast-fashion giant initially aimed for a London listing in the first half of 2024, pending regulatory approvals from the UK and China.
The de minimis exemption, which waived import duties on shipments under $800, allowed Shein to keep prices low in the U.S., its largest market. However, former U.S. President Donald Trump recently announced plans to remove this provision as part of a broader tariff hike on Chinese imports, imposing an additional 10% duty. This change threatens Shein’s profitability and may lead to higher prices for U.S. consumers.
According to analysts, the removal of de minimis could significantly impact Shein and rival Temu, which together accounted for over 30% of daily U.S. package shipments under the rule. The fast-fashion retailer had previously suggested that a London IPO could happen as early as Easter, but the latest trade developments have cast uncertainty over its timeline.
In addition to regulatory challenges, Shein is reportedly lowering its valuation for the potential IPO to around $50 billion—down nearly 25% from its $66 billion valuation in 2023. The move reflects growing headwinds for the company as it navigates economic and political pressures.
Shein has yet to comment on the latest developments. The company’s ability to adjust to shifting trade policies will be crucial in determining its future market position and IPO prospects.


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Instagram Outage Disrupts Thousands of U.S. Users
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 



